Benzinga’s Top Losers (ISIS, ULTI, PKY, KAZ, DF)

ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) decreased 16.85% to $9.19 on 2.21 million shares. Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals announced today that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia met its primary endpoint with a highly statistically significant 28% reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5% for placebo. The 52-week trading range for ISIS is $8.85 - $18.81. ISIS Pharmaceuticals has declined over 44% in the last six months.

The Ultimate Software Group, Inc. (NASDAQ: ULTI) declined 2.57% to $28.10 on 49K shares in the morning trading hours. Ultimate Software announced yesterday that for the first quarter of 2010, it expects total revenues of approximately $55 million. For fiscal 2010, the Company expects total revenues to increase by approximately 18% over those in fiscal 2009. ULTI has surged 99% in the last year. The 52-week trading range for ULTI is $12.40 - $31.78.

Parkway Properties, Inc. (NYSE: PKY) fell 2.25% to $16.96 on 41K shares. The 52-week trading range for PKY is $8.46 - $23.25. Parkway Properties has climbed over 17% in the last year.

BMB Munai Inc. (AMEX: KAZ) plunged 14.05% to $1.04 on 287K shares in the morning trading hours. The 52 week trading range for BMB Munai is $0.33 - $2.02. In the last six months, KAZ has surged over 14%.

Dean Foods Company (NYSE: DF) plummeted 11% to $15.71 on 1.03 million shares. Dean Foods reported today a fourth-quarter net income of $50.3 million, or $0.27 per share, as compared to $66.4 million, or $0.42 per share, in the year-ago period. Revenue declined slightly to $3 billion from $3.1 billion for the same quarter last year. The 52-week trading range for DF is $15.54 - $22.09. Dean Foods has declined over 14% in the last six months.


There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.